Dr David Borenstein, LDN Radio Show 28 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today we are joined by Dr. David Bornstein.  Thank you for joining us, David. 

Dr David Borenstein: Thank you for having me. 

Deirdre - Ireland: Parkinson's (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to welcome Deirdre from Ireland who had Parkinson's disease. Welcome to Deirdre.

Deirdre:  Thank you.

Celia - Ireland: Parkinson's (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Celia from Ireland takes Low Dose Naltrexone (LDN) for Parkinson's disease.

Summary

Low-Dose Naltrexone for Treating MS Symptoms

Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888

Abstract #13: Low-Dose Naltrexone's Tolerability and Effects in Fatigued Patients with Parkinson's Disease: An Open-Label Study

Neurotherapeutics
July 2010
https://www.sciencedirect.com/science/article/abs/pii/S1933721310000681

Dr. Armin Schwarzbach, Infections in Cancer and Autoimmune Disorders. Presented by Markus Berger.

Tracking the spread of Parkinson’s proteins from gut to brain

NIH Research Matters
23 July 2019
https://www.nih.gov/news-events/nih-research-matters/tracking-spread-parkinsons-proteins-gut-brain

Nasha Winters, ND - Navigating the Narrative (2017 Conference) (LDN, low dose naltrexone)

Dr Nasha Winters speaks from experience when she talks about Cancer and how to be proactive in preventing and/or combating it. In her youth she was diagnosed with a terminal Cancer, but discovered the life changes that would turn it around. 

Dr Mark Shuhkman – Psychatric Disorders (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.